Firma ProtaGene, Autor bei PR-Web

Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene

Posted on 12. January 202225. February 2022 by Firma ProtaGene Posted in General Tagged ampersand, analytics, bioanalytix, cell, clinical, discovery, genewerk, healthcare, market, new, patients, protagen, protein, therapy, with

Following the announced merger in July 2021, Protagen Protein Services GmbH, BioAnalytix, Inc., and GeneWerk GmbH today announced their unified operations and re-brand as ProtaGene, a world-leading CRO partner for the biopharmaceutical and cell & gene therapy industries. The three […]

Protagen Protein Services Merges with GeneWerk to Integrate Leading Protein and Gene Therapy Analytic Platforms

Posted on 1. July 202122. August 2023 by Firma ProtaGene Posted in General Tagged ampersand, bioanalytix, cancer, cell, clinical, dkfz, genewerk, heidelberg, heilbronn, market, protagen, rna, therapy, with, zfhn

Protagen Protein Services (PPS) today announced that it will merge with GeneWerk, an Ampersand portfolio company. With the addition of GeneWerk’s unique capabilities in vector safety, characterization, and functionality analysis, PPS will complement its current analytical testing offering in protein […]